The collaboration between the Madrid-based La Paz Hospital, where the 11-year-old patient was treated, and the Hospital Clínic, which develops cell therapy to combat cancer, led to remission of anti-MDA5-positive dermatomyositis, which causes rapid and severe lung damage.